A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...

If you smoke and want to quit, call the national quit line at 1-800-784-8669 to speak with a confidential coach. In what ...

Researchers have just uncovered a hidden inflammatory mechanism that could be the key. In this short video, we break down a ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

The new Indian Council of Medical Research (ICMR) study shows that lung cancer incidence will be the highest in the ...

Medicaid expansion under the ACA improved long-term survival for younger adults with operable lung cancer, despite no earlier ...

“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...

If you smoke and want to quit, call the national quit line at 1-800-784-8669 to speak with a confidential coach.

Trethera Corp. received a $2.7M NIH grant to study combining TRE-515 with KRAS inhibitors for lung cancer. Learn how this ...

The emergence of next-generation KRAS G12C inhibitors has led Verastem Oncology to change course. | The emergence of ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...